A Salvati

672 total citations
37 papers, 491 citations indexed

About

A Salvati is a scholar working on Epidemiology, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, A Salvati has authored 37 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 14 papers in Hepatology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A Salvati's work include Liver Disease Diagnosis and Treatment (17 papers), Hepatitis C virus research (7 papers) and Hepatitis B Virus Studies (6 papers). A Salvati is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Hepatitis C virus research (7 papers) and Hepatitis B Virus Studies (6 papers). A Salvati collaborates with scholars based in Italy, United States and China. A Salvati's co-authors include Anna Solini, Raffaele Sacchi, Eleonora Santini, Alessandro Genovese, Chiara Rossi, P. Chiaradia, Maurizia Rossana Brunetto, Stéphanie Madec, Massimo Chiarugi and Rosa María Bruno and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Hepatology and Diabetologia.

In The Last Decade

A Salvati

36 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Salvati Italy 13 146 113 87 78 76 37 491
J Ludwig Germany 12 183 1.3× 161 1.4× 83 1.0× 171 2.2× 136 1.8× 29 606
Jiani Zhao China 11 15 0.1× 34 0.3× 13 0.1× 52 0.7× 51 0.7× 27 277
Yong-Hyun Park South Korea 15 162 1.1× 74 0.7× 144 1.7× 283 3.6× 190 2.5× 72 681
Kaj Sundqvist Sweden 12 76 0.5× 140 1.2× 34 0.4× 98 1.3× 63 0.8× 19 440
Keary A. Cope United States 10 386 2.6× 41 0.4× 26 0.3× 62 0.8× 47 0.6× 15 1.0k
Yikui Tian United States 15 143 1.0× 9 0.1× 159 1.8× 100 1.3× 32 0.4× 26 701
Jeffrey Leiser United States 12 53 0.4× 11 0.1× 25 0.3× 81 1.0× 93 1.2× 19 505
Peter Recknagel Germany 10 200 1.4× 73 0.6× 23 0.3× 85 1.1× 62 0.8× 11 503
Dana Crişan Romania 15 426 2.9× 311 2.8× 59 0.7× 141 1.8× 69 0.9× 54 814
Naoya Watanabe Japan 10 108 0.7× 11 0.1× 99 1.1× 103 1.3× 31 0.4× 44 440

Countries citing papers authored by A Salvati

Since Specialization
Citations

This map shows the geographic impact of A Salvati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Salvati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Salvati more than expected).

Fields of papers citing papers by A Salvati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Salvati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Salvati. The network helps show where A Salvati may publish in the future.

Co-authorship network of co-authors of A Salvati

This figure shows the co-authorship network connecting the top 25 collaborators of A Salvati. A scholar is included among the top collaborators of A Salvati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Salvati. A Salvati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rovera, Chiara, Francesco Raggi, A Salvati, et al.. (2025). Different formulations of semaglutide and oxidative stress in subjects with type 2 diabetes and MASLD: an open-label, real-life study. Acta Diabetologica. 62(9). 1429–1437. 1 indexed citations
2.
Salvati, A, Silvia Cappelli, G. Ricco, et al.. (2024). Semaglutide for type 2 diabetes control in metabolic dysfunction-associated steatotic liver disease (MASLD): a two-way effect?. Digestive and Liver Disease. 56. S50–S50. 1 indexed citations
3.
Raggi, Francesco, et al.. (2024). Response to semaglutide of non-drinker subjects with type 2 diabetes. Diabetology & Metabolic Syndrome. 16(1). 103–103. 4 indexed citations
4.
Brunetto, Maurizia Rossana, et al.. (2023). Nutritional intervention in the management of non-alcoholic fatty liver disease. Best Practice & Research Clinical Gastroenterology. 62-63. 101830–101830. 1 indexed citations
5.
Lancellotta, Valentina, Loredana Dinapoli, Silvia Mancini, et al.. (2023). PO-1434 HAPPY protocol impact on psychological well-being in patients with gynecological cancer. Radiotherapy and Oncology. 182. S1160–S1161. 1 indexed citations
6.
Salvati, A, Domenico Tricò, G. Ricco, et al.. (2023). Simple proxies of insulin resistance identify obese metabolic dysfunction‐associated fatty liver disease subjects with advanced liver disease. Diabetes/Metabolism Research and Reviews. 40(2). e3736–e3736. 1 indexed citations
7.
Pandey, Avinash, Eileen Fung, Aaron A. Hall, et al.. (2023). P1.02-06 Glucose Deprivation Promotes Pseudo-Hypoxia and De-differentiation in Lung Adenocarcinoma. Journal of Thoracic Oncology. 18(11). S190–S190. 1 indexed citations
8.
Rossi, Chiara, A Salvati, Daniela Campani, et al.. (2022). The P2X7R-NLRP3 and AIM2 Inflammasome Platforms Mark the Complexity/Severity of Viral or Metabolic Liver Damage. International Journal of Molecular Sciences. 23(13). 7447–7447. 12 indexed citations
9.
Bocci, Guido, Paola Orlandi, Maria Laura Manca, et al.. (2022). Predictive Power of Tissue and Circulating Biomarkers for the Severity of Biopsy-Validated Chronic Liver Diseases. Journal of Clinical Medicine. 11(20). 5985–5985. 2 indexed citations
10.
Ricco, G., B. Coco, P. Colombatto, et al.. (2022). Highly dynamic changes of regional HBV epidemiology over two decades. Digestive and Liver Disease. 55(4). 519–526. 10 indexed citations
11.
Salvati, A, Francesco Faita, D. Cavallone, et al.. (2021). Steatosis/steatohepatitis: how sustainable is the non-invasive instrumental differential diagnosis in clinical practice?. Hepatoma Research. 2021. 2 indexed citations
12.
Lascio, Nicole Di, A Salvati, Nicola Martini, et al.. (2018). Steato-Score: Non-Invasive Quantitative Assessment of Liver Fat by Ultrasound Imaging. Ultrasound in Medicine & Biology. 44(8). 1585–1596. 13 indexed citations
13.
Seghieri, Marta, Edoardo Vitolo, Livia Giannini, et al.. (2017). Determinants of glomerular filtration rate following bariatric surgery in individuals with severe, otherwise uncomplicated, obesity: an observational, prospective study. Acta Diabetologica. 54(6). 593–598. 7 indexed citations
14.
Vitolo, Edoardo, Eleonora Santini, A Salvati, et al.. (2016). Metabolic and Hormonal Determinants of Glomerular Filtration Rate and Renal Hemodynamics in Severely Obese Individuals. Obesity Facts. 9(5). 310–320. 12 indexed citations
15.
Bruno, Rosa María, et al.. (2015). Predictive value of dynamic renal resistive index (drin) for renal outcome in type 2 diabetes and essential hypertension: a prospective study. Cardiovascular Diabetology. 14(1). 63–63. 15 indexed citations
16.
Ghiadoni, Lorenzo, Chiara Rossi, Emiliano Duranti, et al.. (2013). P2X7 receptor polymorphisms do not influence endothelial function and vascular tone in neo-diagnosed, treatment-naive essential hypertensive patients. Journal of Hypertension. 31(12). 2362–2369. 11 indexed citations
17.
Bruno, Rosa María, Elena Daghini, Luigi Landini, et al.. (2011). Dynamic evaluation of renal resistive index in normoalbuminuric patients with newly diagnosed hypertension or type 2 diabetes. Diabetologia. 54(9). 2430–2439. 46 indexed citations
18.
Solini, Anna, Chiara Rossi, Eleonora Santini, et al.. (2011). Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation. Journal of Hypertension. 29(10). 1930–1939. 16 indexed citations
19.
Madec, Stéphanie, Chiara Rossi, Massimo Chiarugi, et al.. (2011). Adipocyte P2X7 receptors expression: A role in modulating inflammatory response in subjects with metabolic syndrome?. Atherosclerosis. 219(2). 552–558. 45 indexed citations
20.
Cipolletta, Livio, Maria Antonia Bianco, G. Rotondano, et al.. (2009). Endocytoscopy can identify dysplasia in aberrant crypt foci of the colorectum: a prospective in vivo study. Endoscopy. 41(2). 129–132. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Ludwig Breakdown of academic impact, for papers by Jiani Zhao Breakdown of academic impact, for papers by Yong-Hyun Park Breakdown of academic impact, for papers by Kaj Sundqvist Breakdown of academic impact, for papers by Keary A. Cope Breakdown of academic impact, for papers by Yikui Tian Breakdown of academic impact, for papers by Jeffrey Leiser Breakdown of academic impact, for papers by Peter Recknagel Breakdown of academic impact, for papers by Dana Crişan Breakdown of academic impact, for papers by Naoya Watanabe
Rankless by CCL
2026